The Academy remains supportive of additional efforts to insure usage of affordable health care including important reform to the Medicare’s sustainable growth rate formula. The machine is expected to be released in 2017. ‘In today's complex health care environment it is becoming increasingly important to deliver clinical excellence and successful outcomes for cancer sufferers through radiation treatment plans, which are both effective and efficient,’ said Joshua H. Levine, president and chief executive officer of Accuray. ‘Our goal in partnering with RaySearch is usually to supply solutions that will improve the integration of the TomoTherapy and CyberKnife technology with this customers' oncology section workflow, enabling them to more easily manage the huge volumes of medical data and to streamline their patients' radiation treatments.’ ‘The RaySearch and Accuray collaboration agreement includes two companies focused on offering clinicians with innovative solutions which result in more effective radiation therapy for malignancy sufferers,’ said Johan Lof, president and ceo of RaySearch Laboratories Abdominal .’..The researchers discovered that several factors however, including age, primary sperm count, duration of ethnicity and treatment influenced the reversal aspect. Scientists already knew the creation of sperm can be controlled with the hormone androgen or a combination of androgen and progestagen however the long-term impact of the hormones was not clearly known until now. Currently, a scholarly research involving androgen treatment can be in phase III stage, while another study, involving androgen-progestin mixture is in phase II stage. The prevailing ways of contraception for men, such as condoms or undergoing a vasectomy, could be unacceptable to some couples, the new hormonal treatment offers another option therefore.